Liaison Technologies Announces the Planned Release of Contivo Chameleon 1.0
New product will automate map conversion from EDI translators offering unprecedented portability and cost efficiencies
Liaison Technologies Announces the Planned Release of Contivo Chameleon 1.0
Liaison Technologies, a global business-to-business (B2B) integration services provider, announced today the planned release of Contivo Chameleon 1.0. This will be the first in a series of new integration map conversion products geared towards helping companies dramatically simplify their data migration efforts.
“Liaison is committed to delivering tools and services to help companies migrate to a portable mapping format that can preserve their intellectual property and expand their future integration options,” said Bob Renner, CEO of Liaison Technologies. “With our acquisition of Contivo, Inc. earlier this year, Liaison is in a unique position to fulfill that vision.”
Contivo Chameleon will be the latest product to join Liaison’s market-leading Contivo software suite. The product will simplify the data integration process by enabling the migration of maps and business logic from legacy EDI Translators to an open and portable format.
Users of the Contivo Chameleon product will be able to automate the conversion of maps maintained in legacy translators, thereby minimizing significant effort and cost associated with such conversations. This new capability also allows clients to begin to take advantage of both Java and XSLT.
“The technology landscape is ever changing and companies are looking for ways to take advantage of new, more effective SOA solutions without costly rework,” said Bruce Chen, CTO of Liaison Technologies. “With mapping costs accounting for 40% or more of B2B integration projects, companies are often locked into aging and proprietary EDI translators, B2B platforms and EIA software due to the high cost of migration and specifically re-mapping. Contivo Chameleon will allow companies to break through previously prohibitive switching barriers and enable unprecedented portability and choice for integration solutions and services.”
Beta testing is planned for later this year and Contivo Chameleon version 1.0 will be released in General Availability (GA) during 1Q09.
About Liaison Technologies
Liaison Technologies is a global business-to-business integration services provider. More than 5,000 organizations around the world have benefited from Liaison’s integration, master data management and consulting services. Liaison enables more than 3 million electronic transactions every month for companies like Amazon.com, CHEP International, Cloetta Fazer, Merck & Company, MetLife, Siemens, Stora Enso and U.S. Bank. Liaison has offices in Amsterdam, Atlanta, and Tampere, Finland. For more information, visit www.liaison.com or call 866-336-7378.
Contact:
For Liaison Technologies
Media Contacts
Brian
Boudreaux, 404-929-0091 x211
bboudreaux@arketi.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical added to membership of Russell 3000® Index28.6.2025 01:30:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to
Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 22:44:00 CEST | Press release
Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further
Andersen Consulting udvider sine kompetencer inden for forretningstransformation med tilføjelsen af The Clearing27.6.2025 16:48:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin platform med samarbejdsfirmaet The Clearing, som er en managementkonsulentvirksomhed med speciale i organisatorisk omstilling og lederudvikling. The Clearing blev stiftet i 2009 og rådgiver kunder om komplekse udfordringer ved at afstemme ledelse, strategi, kultur og drift. Firmaet arbejder med føderale agenturer, virksomheder og nonprofitorganisationer med henblik på at skabe målbare forandringer på tværs af forskellige interessenter til gavn for en leders vision og strategi. Med dyb erfaring inden for flere sektorer, herunder national sikkerhed, sundhedspleje og finansielle tjenester, leder The Clearings unikke blanding af talent med ekspertise inden for organisationsudvikling, dataanalyse og visuel rådgivning forretningstransformationer i stor skala og arbejder sammen med kunder og eksperter for at sikre, at rådgivning omsættes til implementering. "Vi leverer transformative resultater, der ikke kun er i overensstemmelse med strategiske mål, men også
PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 16:00:00 CEST | Press release
PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu
STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 14:00:00 CEST | Press release
New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom